New Horizons in AF: Personalised AF therapies in the hands of all EPs
Published: 05 August 2020
-
Views:
430 -
Likes:
7
-
Views:
430 -
Likes:
7
-
16m 48sPart 2 | Session 1 Welcome & Current State of the Art
-
20m 15sPart 2 | Session 2 The Big AF Debate
-
14m 18sPart 3 The Big AF Debate
Overview
Effectively differentiating between potentially life-threatening causes of syncope and more benign causes requires careful evaluation. Tilt-testing is used variably across cardiovascular units around the world. Its sensitivity and specificity in identifying causes for syncope is debated, yet it can provide important diagnostic information if performed and interpreted skilfully and has a role in guiding therapy. We discuss how it is performed, how to interpret the results, and when it can make a difference to the investigation and treatment of patients with syncope.
Key Learning Objectives
With this webinar we aim to:
- Increase knowledge and competence around managing the syncope patient, according to 2018 ESC guidelines on syncope.
- Understand practical implementation strategies of the guidelines.
- Apply guideline diagnostic measures for syncope care.
- Make diagnostic and cost-effective decisions to determine the cause of syncopal episodes.
T arget Audience
This webinar aims to educate the following:
- Cardiologists and electrophysiologists
- Internal medical professionals/primary care
- Emergency physicians/nurses
- Geriatricians
More from this programme
Part 1
New Horizons in AF
1 session | |
New Horizons in AF | Watch now |
Part 2
Welcome & Current State of the Art
Part 3
Personalised AF Therapies in the Hands of All EPs
1 session | |
The Big AF Debate | Watch now |
Faculty Biographies
Transcript